| Literature DB >> 33817126 |
Taskeen Raza1, Saadia Andleeb1, Sidra Rahmat Ullah1, Muhsin Jamal2, Khalid Mehmood3, Muhammad Ali4.
Abstract
Enterococcus faecium, is an important nosocomial pathogen with increased incidence of multidrug resistance (MDR) - specifically Vancomycin resistance. E. faecium constitutes the normal microbiota of the human intestine as well as exists in the hospitals and sewage, thus making the microorganism difficult to eliminate. Phage therapy has gained attention for controlling bacterial MDR infections and contaminations. We have successfully isolated from waste water and characterized a lytic bacteriophage STH1 capable of targeting Vancomycin resistant Enterococcus faecium (VREF) with high specificity. The phage was isolated from sewage water of a hospital at district Dera Ismail Khan, Pakistan. Initial characterization showed that magnesium and calcium ions significantly increased phage adsorption to the host. One step growth experiment showed a latent period of 18 min with burst size of 334 virions per cell. Optimal temperature and pH of the phage was 37°C and 7.0, respectively. Phage application to host strain grown in milk and water (treated and untreated) showed that the phage efficiently controlled bacterial growth. The study suggests that the phage STH1 can serve as potential control agent for E. faecium infections in medical facilities and in other environmental contaminations.Entities:
Keywords: Enterococcus faecium; Phage therapy; Vancomycin resistance
Year: 2018 PMID: 33817126 PMCID: PMC7874677 DOI: 10.1515/biol-2018-0066
Source DB: PubMed Journal: Open Life Sci ISSN: 2391-5412 Impact factor: 0.938
Host range determination of phage STH1 against different clinical bacterial species/isolates
| S.No | Bacteria | Strain/ Isolate | Activity (+/_) |
|---|---|---|---|
| 1 | 1969 | + | |
| 2 | U-523 | _ | |
| 3 | U-781 | _ | |
| 4 | U-790 | _ | |
| 5 | FT-607 | _ | |
| 6 | FT-549 | Slight activity | |
| 7 | 3086 | _ | |
| 8 | 3183 | _ | |
| 9 | 3056 | _ | |
| 10 | 2997 | _ | |
| 11 | U-520 | Slight activity | |
| 12 | 2907 | _ | |
| 13 | 2941 | _ | |
| 14 | 2995 | _ | |
| 15 | 2962 | _ | |
| 16 | 2938 | _ | |
| 17 | 3098 | _ | |
| 18 | 2927 | _ | |
| 19 | 2912 | _ |
Table 1: + = Inhibition , _ = no Inhibition
Figure 1(A), Spot assay for detection of phage and (B), shows plaque assay for detection and confirmation of phage clearly showing plaques ranging in size from 1.5 to 3.5 mm, (C) Transmission electron micrographic (TEM) view of the purified STH1 phage particle (negatively stained preparations). Scale bars, 100 nm.
Figure 2(A) pH stability test of phage at different pH values. At neutral pH maximum number of plaques were observed for STH1 (B) Thermal stability test of phage at different temperature. The optimal temperature for STH1 infection was found to be 37°C. (C)Test for adsorption rate of phage. The ability of divalent metal ions was observed by adding 10 mM CaCl2 or MgCl2 to the mixture of phage STH1 and host bacterium. A significant reduction in free phages in both Ca2+and Mg2+ ions treated samples was observed as compared with control (sample without Ca2+/Mg2+) by applying paired samples t-test (p< 0.05). All the values are mean with standard deviations.
Figure 3(A) One step growth experiment: Curve shows; latent period (18 min); log phase; stationary phase and burst size of 334 virions per cell. (B) Reduction in the growth of planktonic E. faecium by using phage STH1(8.0x107PFU/ml). Values are the means of 4 samples.
Figure 4Effect of phage STH1 on reducing bacterial growth in milk samples when treated with 500 μL of phage filtrate (8.0x107 PFU/ml) post 2 hours of bacterial inoculation. About 2.5 and 3.2 fold reductions were observed in 24 and 48 incubated milk samples, respectively. Reductions in both cases were found significant by applying by t-test (p<0.05) when compared with other control (without phages) samples.